HLB Therapeutics Revenue

HLB Therapeutics had revenue of 15.05B KRW in the quarter ending March 31, 2025, with 17.97% growth. This brings the company's revenue in the last twelve months to 57.22B, up 2.19% year-over-year. In the year 2024, HLB Therapeutics had annual revenue of 54.93B with 4.45% growth.

Revenue (ttm)

57.22B

Revenue Growth

+2.19%

P/S Ratio

5.09

Revenue / Employee

1.19B

Employees

Market Cap

291.40B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	54.93B	2.34B	4.45%
Dec 31, 2023	52.59B	10.19B	24.03%
Dec 31, 2022	42.40B	-1.18B	-2.72%
Dec 31, 2021	43.59B	656.63M	1.53%
Dec 31, 2020	42.93B	-16.04B	-27.20%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,898.69B
Celltrion	3,662.23B
ALTEOGEN	151.65B
Yuhan	2,114.76B
SK Biopharmaceuticals	578.00B
PharmaResearch	392.31B
Peptron	4.30B
LigaChem Biosciences	146.42B

Revenue Rankings